Literature DB >> 3889999

Percutaneous ethanol injection of parathyroid tumors under US guidance: treatment for secondary hyperparathyroidism.

L Solbiati, A Giangrande, L De Pra, E Bellotti, P Cantù, C Ravetto.   

Abstract

In 12 patients with secondary hyperparathyroidism, 13 parathyroid tumors detected with the use of sonography and confirmed by fine-needle aspiration biopsy were treated by percutaneous injection of absolute ethanol under ultrasonographic guidance. Indications for this procedure were recurrence of parathyroid tumors after previous subtotal surgery, high surgical risk, or refusal of surgery. Significant volume reductions were recorded for the larger glands; in the smaller ones, structural changes were observed as well. Clinical and biochemical therapeutic effects were obtained in most cases of single hyperplastic glands treated. Percutaneous alcoholic ablation of enlarged parathyroid glands can be used in cases of secondary hyperparathyroidism when surgery is contraindicated or problematic; it can also improve responsiveness to medical therapy, delaying the need for surgery.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3889999     DOI: 10.1148/radiology.155.3.3889999

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  21 in total

Review 1.  Percutaneous aspiration for hormone levels in the diagnosis of functioning endocrine tumors.

Authors:  J L Doppman
Journal:  Cardiovasc Intervent Radiol       Date:  1991 Jan-Feb       Impact factor: 2.740

2.  Percutaneous autotransplantation of parathyroid tissue into the forearm muscles.

Authors:  H Hidai; T Chiba; Y Takagi; T Mori; T Taniguchi; T Hyodo
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

3.  Prospective comparison of radionuclide, ultrasound, and computed tomography in the preoperative localization of parathyroid glands.

Authors:  H L Carmalt; D J Gillett; J Chu; R A Evans; S Kos
Journal:  World J Surg       Date:  1988-12       Impact factor: 3.352

4.  Understanding Factors Governing Distribution Volume of Ethyl Cellulose-Ethanol to Optimize Ablative Therapy in the Liver.

Authors:  Robert Morhard; Jenna L Mueller; Qishun Tang; Corrine Nief; Erika Chelales; Christopher T Lam; Daniel Adrianzen Alvarez; Michael Rubinstein; David F Katz; Nimmi Ramanujam
Journal:  IEEE Trans Biomed Eng       Date:  2019-12-16       Impact factor: 4.538

5.  Use of FDP and F1P aldolase to detect tumorous and nontumorous tissue damage by ethanol injection of hepatocellular carcinoma.

Authors:  K N Khan; K Nakata; K Nakao; Y Kato; K Eguchi
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

6.  US imaging and color Doppler in patients undergoing inhibitory therapy with calcitriol for secondary hyperparathyroidism.

Authors:  F Pretolesi; E Silvestri; G Di Maio; C Martinoli; F Onetto; P Sala; L E Derchi
Journal:  Eur Radiol       Date:  1997       Impact factor: 5.315

7.  Percutaneous ethanol injection therapy of hepatoma.

Authors:  T Livraghi; C Vettori
Journal:  Cardiovasc Intervent Radiol       Date:  1990 Jun-Jul       Impact factor: 2.740

8.  Multimodality imaging to assess immediate response to irreversible electroporation in a rat liver tumor model.

Authors:  Yue Zhang; Sarah B White; Jodi R Nicolai; Zhuoli Zhang; Derek L West; Dong-Hyun Kim; A Lee Goodwin; Frank H Miller; Reed A Omary; Andrew C Larson
Journal:  Radiology       Date:  2014-02-18       Impact factor: 11.105

Review 9.  Pre-operative localization and interventional treatment of parathyroid tumors: when and how?

Authors:  D L Miller
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

10.  Morphological changes in a hyperfunctioning thyroid adenoma after percutaneous ethanol injection: histological, enzymatic and sub-microscopical alterations.

Authors:  A Crescenzi; E Papini; C M Pacella; R Rinaldi; C Panunzi; L Petrucci; R Fabbrini; G C Bizzarri; V Anelli; F Nardi; V Marinozzi
Journal:  J Endocrinol Invest       Date:  1996-06       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.